跳转至内容
Merck
  • Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments.

Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments.

Journal of immunological methods (2014-07-11)
Michiru Nishi, Nan Jian, Keiko Yamamoto, Haruyo Seto, Yuichi Nishida, Yasuhiro Tonoyama, Nobuyoshi Shimizu, Yoshisuke Nishi
摘要

In vitro assembly of two or three PCR fragments using primers is a common method of constructing scFv fragments for display on the surface of phage. However, mismatch annealing often occurs during in this step, leading to cloning and display of incomplete Fab or scFv fragments. To overcome this limitation, we developed a ligation-based two-fragment assembly (LTFA) protocol that involved separately cloning VH and Vκ fragments into the high-copy-number plasmid pUC18. The VH and Vκ fragments had randomized complementarity-determining region 3 (CDR3) and were joined with a peptidyl linker composed of (G4S)3. Using this approach, complete sequences of scFv fragments were successfully constructed, and the sequencing of 83 scFv clones revealed that none of the sequences, including the linker region, contained deletions or mutations. In contrast, linker sequences generated using a conventional two-fragment PCR assembly (TFPA) protocol often contained sequence anomalies, including large truncations. Using the LTFA protocol, a final library size of 1.0×10(8)cfu was achieved. Examination of the amino acid profiles of the generated scFv fragments within the randomized regions introduced using degenerate codons did not detect any bias from that expected based on stochastic distribution. After several cycles of panning with this library, antigen-specific scFvs against two reference antigens, hen egg lysozyme and streptavidin were detected. In addition, scFvs with specificity against peptidyl antigens in the loop region of the Medaka ortholog of human C6orf89, which encodes a histone deacetylase enhancer that interacts with the bombesin receptor, were also obtained. The LTFA protocol developed here is robust and allows for the easy construction of integral scFv fragments compared with conventional TFPA. Utilizing LTFA, other CDRs can be readily combined. This approach also allows for the in vitro maturation of scFv fragments by separately introducing randomization in CDRs or using error-prone PCR for the amplification of pre-selected sequences as a template scaffold.

材料
货号
品牌
产品描述

Sigma-Aldrich
甲酰胺, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
卡那霉素 硫酸酯 来源于卡那霉素链霉菌, powder, BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
氨苄西林 钠盐, powder or crystals, BioReagent, suitable for cell culture
Sigma-Aldrich
甲酰胺, ≥99.5% (GC), BioReagent, for molecular biology
Sigma-Aldrich
IPTG, ≥99% (TLC), ≤0.1% Dioxane
Sigma-Aldrich
甲酰胺, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
四环素 盐酸盐, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
氨苄西林 钠盐
Sigma-Aldrich
甲胺 溶液, 2.0 M in THF
Sigma-Aldrich
卡那霉素 硫酸酯 来源于卡那霉素链霉菌, Animal Component-free
Sigma-Aldrich
甲胺 溶液, 33 wt. % in absolute ethanol ((denatured with 1% toluene))
Sigma-Aldrich
氨苄西林 钠盐, BioXtra, suitable for cell culture
Sigma-Aldrich
异丙基β-D-1-硫代吡喃半乳糖苷, ≥99% (TLC)
Sigma-Aldrich
甲胺 溶液, 2.0 M in methanol
Sigma-Aldrich
甲胺 溶液, 40 wt. % in H2O
Sigma-Aldrich
异丙基 β-D-硫代半乳糖吡喃糖苷 溶液, ReadyMade IPTG solution for Blue-white screening
Sigma-Aldrich
卡那霉素 硫酸酯 来源于卡那霉素链霉菌, meets USP testing specifications, powder
Sigma-Aldrich
甲酰胺, ACS reagent, ≥99.5%
Sigma-Aldrich
四环素 盐酸盐, ≥95% (European Pharmacopoeia HPLC assay)
Sigma-Aldrich
甲酰胺, spectrophotometric grade, ≥99%
SAFC
异丙基β-D-1-硫代吡喃半乳糖苷